Literature DB >> 9326818

Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients.

H G Koenig1, L K George, K G Meador.   

Abstract

OBJECTIVE: The purpose of this study was to examine antidepressant use by nonpsychiatrists in the treatment of depressed elderly medical inpatients.
METHOD: Patients aged 60 or older who were admitted to medical services at Duke Hospital were evaluated by a geropsychiatrist who used a structured psychiatric interview to identify major or minor depressive disorder. Medical records of depressed patients were reviewed for use of antidepressants and benzodiazepines before admission, during hospitalization, and on discharge. After discharge, depressed patients were contacted four times by telephone at 12-week intervals to inquire about medication use (median follow-up time = 45 weeks).
RESULTS: Of 153 depressed patients, 40.5% received antidepressants at some time during their hospital stay or follow-up period, 25.5% received only benzodiazepines, and 34.0% received neither. The most commonly prescribed antidepressant was amitriptyline (45.2% of treated patients), administered at an average maximum dose of 49 mg/day. Only 15 of 114 untreated depressed patients started antidepressant therapy during hospitalization (nine with amitriptyline). Of 91 depressed patients who did not receive antidepressants either before admission or during hospitalization, only 11% received any antidepressant therapy during the median 11-month follow-up; again, half were treated with amitriptyline at doses of 10-30 mg/day. Intensity of antidepressant therapy was predicted by severity of depressive symptoms, history of psychiatric problems, and higher income.
CONCLUSIONS: A relatively low proportion of depressed older medical inpatients receive treatment with antidepressants. Patients treated with antidepressants often receive potentially dangerous tertiary tricyclics at inadequate doses. Unless depression is identified and treated during medical hospitalization, it is unlikely to be treated adequately after discharge.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326818     DOI: 10.1176/ajp.154.10.1369

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

1.  Recognition and treatment of depression in older adults admitted to acute hospitals in England.

Authors:  Abhishek Shastri; Lina Aimola; Beatrice Tooke; Alan Quirk; Oliver Corrado; Chloe Hood; Mike J Crawford
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

2.  Systematic detection and multidisciplinary care of depression in older medical inpatients: a randomized trial.

Authors:  Martin G Cole; Jane McCusker; Michel Elie; Nandini Dendukuri; Eric Latimer; Eric Belzile
Journal:  CMAJ       Date:  2005-12-05       Impact factor: 8.262

3.  Pharmacodynamics of milnacipran in young and elderly volunteers.

Authors:  I Hindmarch; U Rigney; N Stanley; M Briley
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

Review 4.  Sertraline: a review of its use in the management of major depressive disorder in elderly patients.

Authors:  Richard B R Muijsers; Greg L Plosker; Stuart Noble
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  The increased need for liaison psychiatry in surgical patients due to the high prevalence of undiagnosed anxiety and depression.

Authors:  A M Ni Mhaolain; J S Butler; P F Magill; A E Wood; J Sheehan
Journal:  Ir J Med Sci       Date:  2008-02-07       Impact factor: 1.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.